One touch ultra mini glucometer

Manufactured by Roche

Sourced in Germany

The One Touch Ultra Mini Glucometer is a compact, handheld device designed for monitoring blood glucose levels. It provides a simple and convenient way to quickly obtain accurate glucose readings from a small blood sample.

Automatically generated - may contain errors

Lab products found in correlation

Streptozotocin (stz), by Roche (1 mentions)

Spelling variants of this product

Glucometer (255 citations) One-touch glucometer (15 citations) One Touch Ultra (3 citations) One Touch Ultra Glucometer (2 citations)

2 protocols using one touch ultra mini glucometer

Streptozotocin-Induced Diabetes Mellitus in Pregnant Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols

STZ-induced diabetes mellitus was produced in a batch of normo-glycaemic pregnant (Day 1 of gestation) SD rats (fasting blood glucose level of 75 ± 5 mg/dl). STZ freshly dissolved in 0.1 M cold sodium citrate buffer, pH 4.5, was immediately injected intraperitoneally (60 mg/kg) [31 ]. This dose of streptozotocin (STZ) monohydrate (Sigma, St. Louis, MO, USA) produced diabetes mellitus after 24 h (Day 2 of gestation) of injection and this diabetic state is maintained throughout the experimental schedule.
Glucose levels were tested by using One Touch Ultra Mini Glucometer (Accu-Chek, Roche, Germany) with a drop of blood obtained by tail vein puncture. Rats with blood glucose values of 126 mg/dl in fasted state were considered diabetic.

Osinubi A.A., Medubi L.J., Akang E.N., Sodiq L.K., Samuel T.A., Kusemiju T., Osolu J., Madu D, & Fasanmade O. (2018). A comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats. Toxicology Reports, 5, 832-838.

+ Open protocol

+ Expand

Streptozotocin-Induced Gestational Diabetes

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

The type 1 diabetic condition (Gestational Diabetes Mellitus) was induced in the groups 2 to 5 of the pregnant rats by intraperitoneal injection of double dosage of freshly prepared streptozotocin (STZ) (Sigma, St. Louis, MO, USA) in 0.1M sodium citrate buffer (pH 4.5). The rats were fasted overnight from the night of day 0 of pregnancy and the initial dose of 45mg/Kg b.w.26 (link) was injected on day 1 of pregnancy. The rats were fasted overnight again from the night of day 1 and the second dose of 35mg/Kg b.w.27 ,28 (link) was injected on day 2. The use of the two doses was previously described and the group 1 rats (non-diabetic control) were injected an equal volume of citrate buffer only24 (link),29 . Fasting blood glucose level (diabetic status) was measured 48 h after STZ treatment (day 4 of pregnancy) using One Touch Ultra Mini Glucometer (Accu-chek, Roche, Germany) with a drop of blood obtained by tail vein puncture. The pregnant rats with fasting blood glucose value above 120 mg/dL were considered diabetic as recommended by WHO30 .

Lawal S.K., Adeniji A.A., Sulaiman S.O., Akajewole M.M., Buhari M.O, & Osinubi A.A. (2019). Comparative effects of glibenclamide, metformin and insulin on fetal pancreatic histology and maternal blood glucose in pregnant streptozotocin-induced diabetic rats. African Health Sciences, 19(3), 2491-2504.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!